Visx Eyes Expanded CustomVue Indications, Readies U.S. Presbyopia Trial
This article was originally published in The Gray Sheet
Executive Summary
Visx is counting on expanded hyperopia and myopia claims to its CustomVue wavefront ablation system to spur 8%-10% sales growth in 2005